CAD 0.02
(-20.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -519.82 Thousand | -842.67 Thousand | -785.37 Thousand | -1.52 Million | -124.32 Thousand | -69.84 Thousand |
Net Income | -3.97 Million | -709.3 Thousand | -1.61 Million | 156.64 Thousand | -122.79 Thousand | -76.39 Thousand |
Depreciation & Amortization | 4314.00 | 6161.00 | 8803.00 | 4192.00 | - | - |
Deferred income taxes | -161.24 Thousand | - | - | - | - | - |
Stock-based compensation | 117.61 Thousand | 70.87 Thousand | 181.29 Thousand | 936.14 Thousand | - | - |
Change in working capital | 302.21 Thousand | 52.75 Thousand | 351.12 Thousand | -292.21 Thousand | -1531.00 | 6555.00 |
Other non-cash items | 3.18 Million | -263.15 Thousand | 287.64 Thousand | -2.33 Million | 22.66 | -22.00 |
Investing Cash Flow | 524.77 Thousand | -384.23 Thousand | -2.85 Million | -1.83 Million | - | - |
Investments in PPE | -1.28 Million | -1.73 Million | -1.75 Million | -1.72 Million | - | - |
Acquisitions | - | - | 1092.70 | - | - | - |
Investment purchases | - | - | -1.35 Million | -25.3 Thousand | - | - |
Sales/Maturities of investments | 1.8 Million | 1.35 Million | 262.64 Thousand | - | - | - |
Other Investing Activities | 1809.67 | 1351.55 | -1092.70 | -79.75 Thousand | - | - |
Financing Cash Flow | - | 1.24 Million | - | 6.63 Million | 216.2 Thousand | 223.8 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 984.65 Thousand | - | 7.08 Million | 1706.00 | 266 Thousand |
Other Financing Activities | - | 256.53 Thousand | - | -443.53 Thousand | 214.5 Thousand | -42.19 Thousand |
Accounts receivables | -35 Thousand | 2354.00 | 226.65 Thousand | -297.9 Thousand | -24.19 | 22.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 337.22 Thousand | 50.39 Thousand | 124.46 Thousand | 5690.00 | -1506.81 | 6533.00 |
Cash at beginning of period | 43.6 Thousand | 29.32 Thousand | 3.66 Million | 390.81 Thousand | 298.93 Thousand | 144.97 Thousand |
Cash at end of period | 48.55 Thousand | 43.6 Thousand | 29.32 Thousand | 3.66 Million | 390.81 Thousand | 298.93 Thousand |
Capital Expenditure | -1.28 Million | -1.73 Million | -1.75 Million | -1.72 Million | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 4946.00 | 14.28 Thousand | -3.63 Million | 3.27 Million | 91.88 Thousand | 153.95 Thousand |
Free Cash Flow | -1.8 Million | -2.57 Million | -2.54 Million | -3.25 Million | -124.32 Thousand | -69.84 Thousand |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -153.84 Thousand | -163.87 | -191.87 Thousand | -3.97 Million | -2.5 Million | -463.54 Thousand |
Depreciation & Amortization | 754.00 | 0.76 | 755.00 | 4314.00 | 1079.00 | 1078.00 |
Deferred income taxes | - | - | - | -161.24 Thousand | -131.56 Thousand | - |
Stock-based compensation | - | - | - | 117.61 Thousand | 117.61 | - |
Change in working capital | 217.45 Thousand | 7.87 | 293.44 Thousand | 302.21 Thousand | 355.01 Thousand | 61.59 Thousand |
Other non-cash items | -3218.00 | 116.91 | 10.43 Thousand | 3.18 Million | 2.25 Million | 260.51 Thousand |
Investing Cash Flow | -55.45 Thousand | 36.62 | -144.78 Thousand | 524.77 Thousand | -53.33 Thousand | 183.77 Thousand |
Investments in PPE | -55.45 Thousand | -112.63 | -199.79 Thousand | -1.28 Million | -259.23 Thousand | -279.1 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | -2.00 | 149.24 Thousand | 55 Thousand | 1.8 Million | 205.9 Thousand | 462.87 Thousand |
Other Investing Activities | - | 149.24 | 55.01 | 1809.67 | 205.90 | 462.88 |
Financing Cash Flow | - | - | - | - | -55 Thousand | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -55.00 | - |
Common Stock Issuance | - | - | - | - | -55 Thousand | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | -283.00 | -27.61 | 86.77 Thousand | -35 Thousand | -11.78 Thousand | -7982.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 217.73 Thousand | 35.47 | 206.67 Thousand | 337.22 Thousand | 366.8 Thousand | 69.57 Thousand |
Cash at beginning of period | 14.81 Thousand | 16.53 | 48.55 Thousand | 43.6 Thousand | 65.26 Thousand | 21.84 Thousand |
Cash at end of period | 20.5 Thousand | 14.82 | 16.53 Thousand | 48.55 Thousand | 48.55 Thousand | 65.26 Thousand |
Capital Expenditure | -55.45 Thousand | -112.63 | -199.79 Thousand | -1.28 Million | -259.23 Thousand | -279.1 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 5687.00 | -1.71 | -32.02 Thousand | 4946.00 | -16.7 Thousand | 43.41 Thousand |
Free Cash Flow | 5689.00 | -150.96 | -87.02 Thousand | -1.8 Million | -167.61 Thousand | -419.46 Thousand |
LTRN
LZGI
8393
FALABELLA
CXAI
NXS